Three-Tiered Risk Stratification Model to Predict Progression in Barrett's Esophagus Using Epigenetic and Clinical Features
Fumiaki Sato(Toyohashi University of Technology), Stephen J. Meltzer(Johns Hopkins University), John Abraham(University of Cape Coast), Karsten Schulmann(Klinikum Arnsberg), Yulan Cheng(Johns Hopkins Medicine), Marcia Irene Canto(Johns Hopkins University), Mary Fredericksen(WinnMed), Takatsugu Kan(Hiroshima University), Jean Wang(Princess Margaret Cancer Centre), Bogdan C. Paun(Johns Hopkins University), James P. Hamilton(Johns Hopkins University), Bruce D. Greenwald(University of Maryland, Baltimore), Harris G. Yfantis(University of Maryland, Baltimore), Ziding Feng(The University of Texas MD Anderson Cancer Center), Jian Yang(Qiqihar University), Yuriko Mori(Johns Hopkins University), Stefan David(University of Maryland, Baltimore), Tetsuo Ito(University of Maryland, Baltimore), Yvonne Romero, Tsung‐Teh Wu(Analatom (United States)), Kenneth K. Wang(Mayo Clinic in Arizona), Alexandru Olaru, Zhe Jin(First Hospital of China Medical University)
Cited by 90
Related Papers
Eosinophilic esophagitis: Updated consensus recommendations for children and adults
|Journal of Allergy and Clinical Immunology|2011|2.1k
PINK1 stabilized by mitochondrial depolarization recruits Parkin to damaged mitochondria and activates latent Parkin for mitophagy
|The Journal of Cell Biology|2010|1.9k
Radiofrequency Ablation in Barrett's Esophagus with Dysplasia
|New England Journal of Medicine|2009|1.4k